1. Home
  2. BWAY vs LDI Comparison

BWAY vs LDI Comparison

Compare BWAY & LDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • LDI
  • Stock Information
  • Founded
  • BWAY 2003
  • LDI 2010
  • Country
  • BWAY Israel
  • LDI United States
  • Employees
  • BWAY N/A
  • LDI N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • LDI Finance: Consumer Services
  • Sector
  • BWAY Health Care
  • LDI Finance
  • Exchange
  • BWAY Nasdaq
  • LDI Nasdaq
  • Market Cap
  • BWAY 207.4M
  • LDI 245.6M
  • IPO Year
  • BWAY 2019
  • LDI 2021
  • Fundamental
  • Price
  • BWAY $8.24
  • LDI $1.10
  • Analyst Decision
  • BWAY Strong Buy
  • LDI Sell
  • Analyst Count
  • BWAY 3
  • LDI 3
  • Target Price
  • BWAY $13.17
  • LDI $1.98
  • AVG Volume (30 Days)
  • BWAY 31.1K
  • LDI 1.3M
  • Earning Date
  • BWAY 05-07-2025
  • LDI 05-06-2025
  • Dividend Yield
  • BWAY N/A
  • LDI N/A
  • EPS Growth
  • BWAY N/A
  • LDI N/A
  • EPS
  • BWAY 0.09
  • LDI N/A
  • Revenue
  • BWAY $41,016,000.00
  • LDI $985,646,000.00
  • Revenue This Year
  • BWAY $349.63
  • LDI $32.81
  • Revenue Next Year
  • BWAY $27.16
  • LDI $18.33
  • P/E Ratio
  • BWAY $54.30
  • LDI N/A
  • Revenue Growth
  • BWAY 29.04
  • LDI 5.26
  • 52 Week Low
  • BWAY $4.61
  • LDI $1.01
  • 52 Week High
  • BWAY $11.79
  • LDI $3.23
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 32.71
  • LDI 38.03
  • Support Level
  • BWAY $8.29
  • LDI $1.01
  • Resistance Level
  • BWAY $8.58
  • LDI $1.15
  • Average True Range (ATR)
  • BWAY 0.53
  • LDI 0.13
  • MACD
  • BWAY -0.05
  • LDI -0.00
  • Stochastic Oscillator
  • BWAY 14.81
  • LDI 17.01

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About LDI loanDepot Inc.

loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.

Share on Social Networks: